Ahmed Pasha is a Cardiology physician. OpenAlex indexes 68 publications with 699 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1340 Charles St Ste 300
Rockford, IL 611042200
Telephone
779-696-5888Provider last certified this registry record 11 May 2026.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202528 payments
- Bard Peripheral Vascular, Inc.Program year20251 payment
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.6%Beta blocker26.7%Metoprolol Succinate80%Metoprolol Tartrate20%Part D<11 patientsStatin19.9%Atorvastatin Calcium100%Part D≥13 patients+ 4 more classes in this area
Blood & clotting
15%P2Y12 inhibitor7.8%Clopidogrel100%Part D<11 patientsFactor Xa inhibitor7.3%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
6.3%SGLT2 inhibitor6.3%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Journal of Cardiovascular Development and Disease
2024 - VERTICAL TRANSMISSION OF METHICILLIN RESISTANT STAPHYLOCOCCAL AUREUS (MRSA) WITH SIMULTANEOUS ENDOCARDITIS IN THE MOTHER AND NEONATE
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”